Form 4: Emergent BioSolutions Director Sujata Tyagi Dayal Reports Stock and Option Grants

Director Sujata Tyagi Dayal reports the acquisition of restricted stock units and stock options in Emergent BioSolutions Inc.

Summary

• On May 23, 2024, Sujata Tyagi Dayal, a director of Emergent BioSolutions Inc., reported transactions involving the company's stock.
• Dayal acquired 17,430 restricted stock units (RSUs) and 25,748 stock options as part of an annual grant for Board and Committee service.
• The RSUs will vest on the day prior to the one-year anniversary of the grant date, contingent on Dayal remaining a board member.
• The stock options, with an exercise price of $5.02, also vest on the same date, subject to continued board membership.
• Following these transactions, Dayal beneficially owns 63,129 shares of Emergent BioSolutions Inc. common stock and 25,748 stock options.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock and options to a director, indicating a positive alignment of interests between the director and the company's shareholders. There are no indications of negative sentiment.

Positives

• The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
• The vesting requirements incentivize continued service on the board of directors.

Future Outlook

The RSUs and stock options will vest on the day prior to the one-year anniversary of the grant date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

Industry Context

This filing is a routine disclosure of stock and option grants to a director, which is a common practice in publicly traded companies to incentivize and retain board members.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation practices for directors in publicly traded companies, particularly in the biotech industry.
• The vesting schedules and terms are generally consistent with industry norms for director compensation packages.
• Comparable companies such as Moderna, BioNTech, and Novavax also utilize stock options and RSUs as part of their director compensation.

Stakeholder Impact

• The grant of equity to a director can positively impact shareholders by aligning the director's interests with the company's long-term success.
• The vesting requirements incentivize the director to remain engaged and contribute to the company's strategic direction.

Key Dates